Corporate Credit at a Crossroads?

Corporate Credit at a Crossroads?

Our Head of Corporate Credit Research looks at the Fed’s approach to rate cuts, seasonal trends and the US election to explain why the next month represents a crucial window for credit’s future.


----- Transcript -----


Welcome to Thoughts on the Market. I'm Andrew Sheets, head of Corporate Credit Research at Morgan Stanley. Along with my colleagues bringing you a variety of perspectives, today I'll discuss why the next month is a critical window for credit.

It's Thursday, September 12th at 9am in New York.

We’ve liked corporate credit as an asset class this year and think the outlook over the next 6-12 months remains promising. At a high level, credit likes moderation, and that continues to be exactly what Morgan Stanley’s economists are forecasting; with moderate growth, moderate inflation, and moderating policy in the US and Europe. Meanwhile, at the ground level, corporate balance sheets are in good shape, and demand for fixed income remains strong, dynamics that we think are unlikely to shift quickly.

But this good credit story is now facing a critical window. As we’ve discussed recently on this program, the Fed has taken a risk with monetary policy, continuing to keep interest rates elevated despite increasing indications that they should be lower. U.S. inflation has been coming down rapidly, to the point where the market now thinks the rate of inflation over the next two years will be below what the Fed is targeting. The labor market is slowing, and government bond markets are now assuming that the Fed will have to make much more significant adjustments to policy.

And so, this becomes a race. If the economic data can hold up for the next few months, while the Fed does make those first gradual rate cuts, it will help reassure markets that monetary policy is reasonable and in-line with the underlying economy. But if the data weakens more now, the market is vulnerable. Monetary policy works with a lag, meaning rate cuts are not going to help anytime soon. And so, it becomes easier for the market to worry that growth is slowing too much, and that the cavalry of rate cuts will be too late to arrive.

The second immediate challenge is so-called seasonality. Over almost a century, September has seen significantly weaker performance relative to any other month. Seasonality always has an element of mysticism to it, but in terms of specific reasons why markets tend to struggle around this time of year, we’d point to two factors. First, after a summer lull, you tend to see a lot of issuance, including corporate bonds issuance. And for Equities, September often sees more negative earnings revisions, as companies aim to bring full-year estimates in line with reality. Lots of supply and weaker earnings revisions are often a tough combination.

A final element of this critical window is the approaching US election. This appears to be an extremely close race between candidates with very different policy priorities. If investors get more nervous that monetary policy is mis-calibrated, or seasonality is unhelpful, the approaching election provides yet another reason for investors to hold back.

All of this is why we think the next month is a critical window for credit, and why we’d exercise a little bit more caution than we have so far this year. But we also think any weakness is going to be temporary. By early November, the US election will be over, and we think growth will be holding up, inflation will keep coming down, and interest rate cuts will be well underway. And while September is historically a bad month for stocks and credit, late-October onward is a different and much better story. Any near-term softness could still give way to a stronger finish to the year.

Thanks for listening. If you enjoy the show, leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

Episoder(1509)

Special Episode: COVID-19 - Preparing for Fall's Second Wave

Special Episode: COVID-19 - Preparing for Fall's Second Wave

In the first of a special two part episode, we talk with biotech equity analyst Matthew Harrison about new case projections ahead of fall and flu season.

23 Jul 20208min

Michael Zezas: States Look to D.C. to Fill Budget Holes

Michael Zezas: States Look to D.C. to Fill Budget Holes

Local and state governments across the U.S. are eagerly watching whether a new round of stimulus will help them address budget shortfalls. Will Congress deliver?

22 Jul 20202min

Mike Wilson: Adapting to The Ninth Wonder of the World

Mike Wilson: Adapting to The Ninth Wonder of the World

Understanding the regime of financial repression we are under, and recent changes in it, is key for successful investment. Chief Investment Officer, Mike Wilson explains.

20 Jul 20204min

Andrew Sheets: Bracing for Challenges Ahead

Andrew Sheets: Bracing for Challenges Ahead

While July contains a number of potentially positive market events, August and September could present a number of potentially problematic ones.

17 Jul 20203min

Michael Zezas: Coronavirus - Why Another Stimulus Deal is Likely

Michael Zezas: Coronavirus - Why Another Stimulus Deal is Likely

Could a new $1 trillion stimulus deal make its way through the halls of Congress before the summer recess? Why the likelihood of a deal is increasing.

15 Jul 20202min

Mike Wilson: U.S. Markets Weigh Optimism; Uncertainty

Mike Wilson: U.S. Markets Weigh Optimism; Uncertainty

U.S. equities—tech stocks in particular—have powered higher since March lows, but investors are still parsing Q2 earnings, a coming election and rising COVID-19 cases.

13 Jul 20204min

Andrew Sheets: Pressure Testing the “Overoptimistic Markets” Argument

Andrew Sheets: Pressure Testing the “Overoptimistic Markets” Argument

The sharp rebound in stock and corporate bond markets has made some question if markets are a bit too upbeat about a speedy recovery. There’s just one problem with this view.

10 Jul 20203min

Michael Zezas: How Should Investors Ride a Potential “Blue Wave”?

Michael Zezas: How Should Investors Ride a Potential “Blue Wave”?

Although the U.S. election is anything but predictable four months away, investors may still want to consider how markets would react to a Democrat sweep.

8 Jul 20202min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
lydartikler-fra-aftenposten
rss-borsmorgen-okonominyhetene
kommentarer-fra-aftenposten
rss-vass-knepp-show
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
utbytte
okonomiamatorene
stormkast-med-valebrokk-stordalen
rss-rettssikkerhet-bak-fasaden-pa-rettsstaten-norge-en-podcast-av-sonia-loinsworth
rss-sunn-okonomi
lederpodden
arcticpodden